Skip to Content

  • Search

View Additional Section Content

A Phase 2a Randomized Double-Blinded, Placebo and Active Controlled Two Cohort Two Doses Cross-Over Multi-Center Study to Assess Efficacy of a Once Daily Administration of a Phosphodiesterase 5 Inhibitor (PF-00489791) for the Treatment of Vasospasm in Primary and Secondary Raynaud’s Phenomenon

Principal Investigator(s)
C. Michael Franklin, M.D. (Sub-Investigator)
Mark Lopatin, M.D. (Sub-Investigator)
David J. Chesner, D.O. (Sub-Investigator)
Elana R. Eisner, M.D. (Sub-Investigator)
Marguerite L. McGarvey, M.D. (Sub-Investigator)
Dennis A. Jerdan, M.D. (Sub-Investigator)
Charles H. Pritchard, M.D.

Clinical Trial Categories

  • Raynaud's
Contact
Sue Falbo at 215-657-9977

Location

  • Rheumatic Disease Associates, Ltd.

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a Test
Request an Appointment

215-481-EXAM

Clinical Trials Details